Your shopping cart is currently empty

8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 μM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),15(S)-DiHETE and LTB4 in the rat hind paw pain model.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 μg | $345 | 35 days | 35 days | |
| 50 μg | $649 | 35 days | 35 days | |
| 100 μg | $1,220 | 35 days | 35 days |
| Description | 8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 μM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),15(S)-DiHETE and LTB4 in the rat hind paw pain model. |
| Molecular Weight | 336.47 |
| Formula | C20H32O4 |
| Cas No. | 80234-65-7 |
| Smiles | C(\[C@H](C/C=C\CCCC(O)=O)O)=C/C=C\C=C\[C@H](CCCCC)O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: >50 mg/mL (per Rao Maddipati), Sonication is recommended. DMSO: >50 mg/mL (per Rao Maddipati), Sonication is recommended. Ethanol: >50 mg/mL (per Rao Maddipati), Sonication is recommended. PBS (pH 7.2): >1 mg/mL (from 13(S)-HODE), Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.